Effect of TP53 rs1042522 on the susceptibility of patients to oral squamous cell carcinoma and oral leukoplakia: A meta-analysis

by Cui, J.-T, Gao, W., Sun, Z.
Published 2018

The MDM2 and CDKN2A Copy-number-variation Influence the TP53-signature-score in Wild-type TP53 Luminal Type Breast Cancer

by Fujii, T., Han, M., Hosoya, M., Kato, S., Kido, H., Onishi, M., Wen, X., Yamaguchi, S.
Published 2022

The potential diagnosis role of TP53 mutation in advanced bladder cancer: A meta-analysis

by Jiang, N., Liao, Y., Tang, H., Wang, K., Wang, M., Wang, Y.
Published 2021

Evaluation of Tumor DNA Sequencing Results in Patients with Gastric and Gastroesophageal Junction Adenocarcinoma Stratified by TP53 Mutation Status

by Cen, L., Dineen, S.P, Fontaine, J., Frakes, J., Hoffe, S.E, Mehta, R., Mo, Q., Pimiento, J.M, Walko, C.M, Wood, A.C, Zhang, Y.
Published 2022

Deciphering the Increased Prevalence of TP53 Mutations in Metastatic Prostate Cancer

by Dong, Y., Sartor, O., Zhang, K., Zhang, W.
Published 2022

The Inhibitory Response to PI3K/AKT Pathway Inhibitors MK-2206 and Buparlisib Is Related to Genetic Differences in Pancreatic Ductal Adenocarcinoma Cell Lines

by Al-Ali, R., Ameziane, N., Bauer, P., Escobar, H.M, Junghanss, C., Kong, W., Krake, S., Lerch, M.M, Ma, Y., Parveen, A., Radefeldt, M., Sekora, A., Sender, S., Weiss, F.U, Zechner, D.
Published 2022

TP53/BRAF mutation as an aid in predicting response to immune-checkpoint inhibitor across multiple cancer types

by Cao, J.-Z, Feng, Z.-H, Li, P.-J, Liu, F., Luo, J.-H, Tang, Y.-M, Wei, J.-H, Yao, G.-S
Published 2022

Inherited TP53 Variants and Risk of Prostate Cancer

by Abida, W., AlDubayan, S.H, Carlo, M.I, Cheng, H.H, Dubard-Gault, M., Garber, J.E, Greenberg, S.E, Gulati, R., Hausler, R., Hyman, S., Kohlmann, W., Konnick, E.Q, Laurino, M., Le, A., Ledet, E.M, Lee, D.J, Maese, L.D, Mandelker, D., Maxwell, K.N, Montgomery, B., Morris, M.J, Morrison, C., Naumer, A., Naylor, L., Nelson, P.S, Nguyen, B., Nicolosi, P., Nussbaum, R.L, Offit, K., Powers, J., Pritchard, C.C, Sartor, O., Schiffman, J.D, Schwartz, L.E, Shirts, B.H, Stadler, Z., Stopfer, J., Vagher, J., Van Allen, E.M, Vijai, J., Walsh, M.F
Published 2022

Abnormal TP53 Predicts Risk of Progression in Patients With Barrett's Esophagus Regardless of a Diagnosis of Dysplasia

by Akarca, F.G, Bass, A.J, Kim, A., Lash, R., Noffsinger, A., Nowden, L., Rara, M., Redston, M., Stachler, M.D, Stapleton, D.
Published 2022

The utility of TP53 and PIK3CA mutations as prognostic biomarkers in salivary adenoid cystic carcinoma

by Adderley, H., Betts, G., Feeney, L., Hapuarachi, B., Harrington, K., Hodgson, C., Hussell, T., Metcalf, R., Morgan, D., Rack, S., Wallace, A.J
Published 2021

The Inhibitory Response to PI3K/AKT Pathway Inhibitors MK-2206 and Buparlisib Is Related to Genetic Differences in Pancreatic Ductal Adenocarcinoma Cell Lines

by Al-Ali, R., Ameziane, N., Bauer, P., Escobar, H.M, Junghanss, C., Kong, W., Krake, S., Lerch, M.M, Ma, Y., Parveen, A., Radefeldt, M., Sekora, A., Sender, S., Weiss, F.U, Zechner, D.
Published 2022

Genomic landscape of advanced endometrial cancer analyzed by targeted next-generation sequencing and the cancer genome atlas (TCGA) dataset

by Cho, H.W, Chun, Y., Gim, J.-A, Hong, J.H, Lee, J.K, Ouh, Y.-T
Published 2022

Association between ТР53, MDM2 and NQO1 gene polymorphisms and viral load among women with human papillomavirus

by AlBosale, A.H, Mashkina, E.V
Published 2022